Related Experiment Video
Updated: May 12, 2026
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Extracorporeal Membrane Oxygenation in Pediatric Patients With Congenital Heart Disease: Surgical Considerations
Rachel D Vanderlaan1, David J Barron1
1Cardiovascular Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada.
Insights
Extracorporeal membrane oxygenation (ECMO) is increasingly used in children to support failing lungs and hearts. Tailored ECMO strategies and careful patient selection are crucial for improving survival in pediatric congenital heart disease.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Critical Care Medicine
Background:
- Extracorporeal membrane oxygenation (ECMO) use in pediatrics has risen.
- ECMO supports pulmonary and cardiovascular deterioration.
- It is vital for neonates and children with congenital heart disease (CHD).
Purpose of the Study:
- To review ECMO's role in pediatric congenital heart disease.
- To highlight the importance of tailored cannulation strategies.
- To emphasize patient selection and rapid deployment for better outcomes.
Main Methods:
- Literature review on pediatric ECMO for CHD.
- Analysis of ECMO application in preoperative and postoperative settings.
- Discussion of cannulation strategies based on patient physiology.
Main Results:
- ECMO offers a rescue option for critical pediatric cardiopulmonary failure.
- Appropriate ECMO management can improve survival rates in CHD patients.
- Individualized ECMO approaches are essential for optimal results.
Conclusions:
- ECMO is a valuable tool for managing pediatric congenital heart disease.
- Optimizing ECMO cannulation and patient selection enhances outcomes.
- Further research into tailored ECMO protocols for CHD is warranted.
Abstract:
The use of extracorporeal membrane oxygenation (ECMO) in the paediatric population has increased over time, with the ability to rescue pulmonary and cardiovascular deterioration. ECMO can be utilised by neonates and children with congenital heart disease in both preoperative and postoperative settings to improve survival and minimise morbidity. ECMO cannulation strategy must be tailored to the age, weight, and physiologic state of the patient. Careful patient selection and rapid deployment of ECMO may improve survival and morbidity in patients with congenital heart disease.
